Cortexyme, Inc.
(NASDAQ : CRTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 8.73%147.660.0%$994.17m
AMGNAmgen, Inc. 0.87%255.261.5%$856.48m
GILDGilead Sciences, Inc. 0.51%64.801.0%$543.24m
VRTXVertex Pharmaceuticals, Inc. 1.51%273.731.9%$497.98m
REGNRegeneron Pharmaceuticals, Inc. 1.37%692.802.6%$444.80m
ILMNIllumina, Inc. 5.95%258.063.3%$337.13m
NVAXNovavax, Inc. 17.46%55.2975.7%$314.14m
BIIBBiogen, Inc. 0.97%206.201.8%$237.64m
BNTXBioNTech SE 5.57%166.960.0%$224.59m
SNSSSunesis Pharmaceuticals, Inc. 2.38%2.150.7%$150.29m
EXASEXACT Sciences Corp. 7.96%53.8317.7%$134.25m
TECHBio-Techne Corp. 5.81%386.564.5%$107.96m
TXG10X Genomics, Inc. 11.91%52.990.0%$106.79m
BMRNBioMarin Pharmaceutical, Inc. 2.68%80.974.2%$95.42m
CRSPCRISPR Therapeutics AG 5.63%58.340.6%$85.42m

Company Profile

Cortexyme, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline composed of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.